(VIANEWS) – SunPower Corporation (SPWR), Enphase Energy (ENPH), Eli Lilly and Company (LLY) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SunPower Corporation (SPWR)
32.1% sales growth and 13.66% return on equity
SunPower Corporation delivers solar solutions worldwide. It operates through Residential, Light Commercial; Commercial and Industrial Solutions; and Others segments. The company provides solar energy solutions, including sales to its third-party dealer network and resellers, storage solutions, cash and loan sales, and long-term leases directly to end customers; and sells turn-key engineering, procurement, and construction services, as well as sells energy under power purchase agreements. It also offers commercial roof, carport, and ground mounted systems; and post-installation operations and maintenance services. In addition, the company provides residential leasing program services, as well as sells inverters manufactured by third parties. The company also serves investors, financial institutions, project developers, electric utilities, independent power producers, commercial and governmental entities, production home builders, residential owners, and small commercial building owners. The company was incorporated in 1985 and is headquartered in San Jose, California. SunPower Corporation is a subsidiary of Total Energies Nouvelles Activités USA.
Earnings Per Share
As for profitability, SunPower Corporation has a trailing twelve months EPS of $0.31.
PE Ratio
SunPower Corporation has a trailing twelve months price to earnings ratio of 35.08. Meaning, the purchaser of the share is investing $35.08 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.66%.
Volume
Today’s last reported volume for SunPower Corporation is 2662770 which is 42.23% below its average volume of 4609700.
2. Enphase Energy (ENPH)
27% sales growth and 75.69% return on equity
Enphase Energy, Inc., together with its subsidiaries, designs, develops, manufactures, and sells home energy solutions for the solar photovoltaic industry in the United States and internationally. The company offers semiconductor-based microinverter, which converts energy at the individual solar module level, and combines with its proprietary networking and software technologies to provide energy monitoring and control services. It also provides microinverter units and related accessories, an IQ gateway; IQ batteries; the cloud-based Enlighten monitoring service; storage solutions; and electric vehicle charging solutions; and design, proposal, permitting, and lead generation services. The company sells its solutions to solar distributors; and directly to large installers, original equipment manufacturers, strategic partners, and homeowners, as well as through its legacy product upgrade program or online store. Enphase Energy, Inc. was incorporated in 2006 and is headquartered in Fremont, California.
Earnings Per Share
As for profitability, Enphase Energy has a trailing twelve months EPS of $3.43.
PE Ratio
Enphase Energy has a trailing twelve months price to earnings ratio of 47.22. Meaning, the purchaser of the share is investing $47.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 75.69%.
Moving Average
Enphase Energy’s value is way below its 50-day moving average of $190.23 and way below its 200-day moving average of $250.64.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Enphase Energy’s EBITDA is 11.37.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 18.7% and 10.4%, respectively.
Yearly Top and Bottom Value
Enphase Energy’s stock is valued at $161.96 at 11:22 EST, way below its 52-week high of $339.92 and above its 52-week low of $152.15.
3. Eli Lilly and Company (LLY)
14.7% sales growth and 54.79% return on equity
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Earnings Per Share
As for profitability, Eli Lilly and Company has a trailing twelve months EPS of $6.33.
PE Ratio
Eli Lilly and Company has a trailing twelve months price to earnings ratio of 69.71. Meaning, the purchaser of the share is investing $69.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 54.79%.
Moving Average
Eli Lilly and Company’s value is way above its 50-day moving average of $377.08 and way above its 200-day moving average of $347.77.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 11, 2023, the estimated forward annual dividend rate is 4.52 and the estimated forward annual dividend yield is 1.04%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 10.9%, now sitting on 27.69B for the twelve trailing months.
Volume
Today’s last reported volume for Eli Lilly and Company is 1744750 which is 46.22% below its average volume of 3244540.
4. Rollins (ROL)
14.5% sales growth and 31.98% return on equity
Rollins, Inc., through its subsidiaries, provides pest and wildlife control services to residential and commercial customers in the United States and internationally. The company offers pest control services to residential properties protecting from common pests, including rodents, insects, and wildlife. It also provides workplace pest control solutions for customers across various end markets, such as healthcare, foodservice, and logistics. In addition, the company offers termite protection services and ancillary services. It serves clients directly, as well as through franchisee operations. Rollins, Inc. was incorporated in 1948 and is headquartered in Atlanta, Georgia.
Earnings Per Share
As for profitability, Rollins has a trailing twelve months EPS of $0.78.
PE Ratio
Rollins has a trailing twelve months price to earnings ratio of 52.74. Meaning, the purchaser of the share is investing $52.74 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.98%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 20% and 13.6%, respectively.
Sales Growth
Rollins’s sales growth is 12.6% for the present quarter and 14.5% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Rollins’s EBITDA is 7.09.
Moving Average
Rollins’s worth is higher than its 50-day moving average of $39.11 and higher than its 200-day moving average of $37.63.
5. National Oilwell Varco (NOV)
14.2% sales growth and 6.38% return on equity
National Oilwell Varco, Inc. designs, constructs, manufactures, and sells systems, components, and products for oil and gas drilling and production worldwide. It operates through three segments: Wellbore Technologies, Completion & Production Solutions, and Rig Technologies. The company offers various equipment and technologies used to perform drilling operations. It also provides solids control and waste management equipment and services; drilling fluids; portable power generation products; drill and wired pipes; drilling optimization and automation services; tubular inspection, repair, and coating services; instrumentation, and measuring and monitoring services; downhole and fishing tools; steerable technologies; and drill bits. The company offers equipment and technologies for hydraulic fracture stimulation, including pressure pumping trucks, blenders, sanders, hydration units, injection units, flowline, and manifolds; well intervention, such as coiled tubing units, coiled tubing, and wireline units, as well as blowout preventers and tools; onshore production comprising fluid processing systems, composite pipes, surface transfer and progressive cavity pumps, and artificial lift systems; offshore production that include fluid processing systems, floating production systems, and subsea production technologies; and connectors for conductor pipes. It also provides substructures, derricks, and masts; cranes; jacking systems; pipe lifting, racking, rotating, and assembly systems; mud pumps; blowout preventers; drives and generators; rig instrumentation and control systems; equipment components for offshore wind construction vessels; mooring, anchor, and deck handling machinery; and pipelay and construction systems. The company offers spare parts, repair, and rentals, as well as remote equipment monitoring, technical support, field service, and customer training services. National Oilwell Varco, Inc. was founded in 1862 and is based in Houston, Texas.
Earnings Per Share
As for profitability, National Oilwell Varco has a trailing twelve months EPS of $0.77.
PE Ratio
National Oilwell Varco has a trailing twelve months price to earnings ratio of 19.55. Meaning, the purchaser of the share is investing $19.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.38%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 66.7% and 325%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 26.7%, now sitting on 7.65B for the twelve trailing months.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 15, 2023, the estimated forward annual dividend rate is 0.2 and the estimated forward annual dividend yield is 1.28%.
6. First Industrial Realty Trust (FR)
13.3% sales growth and 16.89% return on equity
First Industrial Realty Trust, Inc. (NYSE: FR) is a leading fully integrated owner, operator, and developer of industrial real estate with a track record of providing industry-leading customer service to multinational corporations and regional customers. Across major markets in the United States, our local market experts manage, lease, buy, (re)develop, and sell bulk and regional distribution centers, light industrial, and other industrial facility types. In total, we own and have under development approximately 64.1 million square feet of industrial space as of September 30, 2020.
Earnings Per Share
As for profitability, First Industrial Realty Trust has a trailing twelve months EPS of $2.86.
PE Ratio
First Industrial Realty Trust has a trailing twelve months price to earnings ratio of 18.21. Meaning, the purchaser of the share is investing $18.21 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.89%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 68.2% and a negative 68.1%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 41.1%, now sitting on 591.41M for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 28, 2023, the estimated forward annual dividend rate is 1.28 and the estimated forward annual dividend yield is 2.45%.
Volume
Today’s last reported volume for First Industrial Realty Trust is 515244 which is 30.94% below its average volume of 746126.
7. XP (XP)
10.3% sales growth and 22.76% return on equity
XP Inc. provides financial products and services in Brazil. It operates XP Platform, an open product platform that provides clients to access investment products in the market comprising brokerage securities, fixed income securities, mutual, hedge, and private equity funds; derivatives and synthetic instruments; credit cards; loan operations/collateralized credit products; pension and social security funds, and life and travel insurance products; and other investment products comprising real estate funds, and equity and debt capital markets solutions, as well as wealth management services. The company offers brokerage and issuer services to institutional and corporate clients. It also manages mutual funds focused on stocks and macro strategies distributed to retail and to institutional clients; funds and managed portfolios for high-net-worth retail clients, and proprietary treasury funds; and passive mutual funds that track market indexes, and mutual and investment funds focused on fixed income, credit, real estate, infrastructure, and other alternative strategies. In addition, the company offers securities brokerage services for institutional and retail investors; interdealer brokerage services for institutional traders; and commercial and investment banking products, such as loan operations and transactions in the foreign exchange markets and deposits, as well as develops and sells financial education courses and events online and in person to retail clients. It offers its sell products and services through its omni-channel distribution network and online portals. XP Inc. was founded in 2001 and is based in Grand Cayman, Cayman Islands.
Earnings Per Share
As for profitability, XP has a trailing twelve months EPS of $1.35.
PE Ratio
XP has a trailing twelve months price to earnings ratio of 12.8. Meaning, the purchaser of the share is investing $12.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.76%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
XP’s EBITDA is 6.19.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 15.2% and a negative 2.9%, respectively.
Moving Average
XP’s worth is way higher than its 50-day moving average of $12.69 and above its 200-day moving average of $16.59.
Revenue Growth
Year-on-year quarterly revenue growth declined by 5.5%, now sitting on 12.95B for the twelve trailing months.
8. Core Laboratories N.V. (CLB)
9% sales growth and 13.06% return on equity
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products; and proprietary and joint industry studies. The Production Enhancement segment offers services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amstelveen, the Netherlands.
Earnings Per Share
As for profitability, Core Laboratories N.V. has a trailing twelve months EPS of $0.51.
PE Ratio
Core Laboratories N.V. has a trailing twelve months price to earnings ratio of 42.71. Meaning, the purchaser of the share is investing $42.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.06%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 4, 2023, the estimated forward annual dividend rate is 0.04 and the estimated forward annual dividend yield is 0.19%.
